ATE271853T1 - Vorrichtung und verfahren zur herstellung von kristallinen partikeln - Google Patents

Vorrichtung und verfahren zur herstellung von kristallinen partikeln

Info

Publication number
ATE271853T1
ATE271853T1 AT00973049T AT00973049T ATE271853T1 AT E271853 T1 ATE271853 T1 AT E271853T1 AT 00973049 T AT00973049 T AT 00973049T AT 00973049 T AT00973049 T AT 00973049T AT E271853 T1 ATE271853 T1 AT E271853T1
Authority
AT
Austria
Prior art keywords
mixing chamber
crystalline particles
substance
liquid
reservoir
Prior art date
Application number
AT00973049T
Other languages
English (en)
Inventor
Alan Ronald Ferrie
Andrew Patrick Savage
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE271853T1 publication Critical patent/ATE271853T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0059—General arrangements of crystallisation plant, e.g. flow sheets
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/10—Mixing by creating a vortex flow, e.g. by tangential introduction of flow components
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/40—Mixing liquids with liquids; Emulsifying

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Oxygen, Ozone, And Oxides In General (AREA)
  • Steroid Compounds (AREA)
AT00973049T 1999-11-03 2000-11-03 Vorrichtung und verfahren zur herstellung von kristallinen partikeln ATE271853T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9925934.3A GB9925934D0 (en) 1999-11-03 1999-11-03 Novel apparatus and process
GBGB0024511.8A GB0024511D0 (en) 1999-11-03 2000-10-06 Novel apparatus and process
PCT/GB2000/004237 WO2001032125A2 (en) 1999-11-03 2000-11-03 Apparatus and process for preparing crystalline particles

Publications (1)

Publication Number Publication Date
ATE271853T1 true ATE271853T1 (de) 2004-08-15

Family

ID=10863815

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00973049T ATE271853T1 (de) 1999-11-03 2000-11-03 Vorrichtung und verfahren zur herstellung von kristallinen partikeln

Country Status (25)

Country Link
EP (2) EP1466595A1 (de)
JP (1) JP4700247B2 (de)
KR (1) KR20020047322A (de)
CN (1) CN1409627A (de)
AT (1) ATE271853T1 (de)
AU (1) AU768915B2 (de)
BR (1) BR0015271A (de)
CA (1) CA2389908A1 (de)
CZ (1) CZ20021555A3 (de)
DE (1) DE60012558T2 (de)
DK (1) DK1225875T3 (de)
ES (1) ES2225247T3 (de)
GB (2) GB9925934D0 (de)
HK (1) HK1045268B (de)
HU (1) HUP0203278A3 (de)
IL (1) IL149366A0 (de)
MX (1) MXPA02004394A (de)
NO (1) NO20022059L (de)
NZ (1) NZ518565A (de)
PL (1) PL356746A1 (de)
PT (1) PT1225875E (de)
SI (1) SI1225875T1 (de)
TR (1) TR200402709T4 (de)
WO (1) WO2001032125A2 (de)
ZA (1) ZA200203434B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7199242B2 (en) 2001-08-02 2007-04-03 Lg Life Sciences Limited Processes for the production of amino-protected derivatives of 4-aminomethylene-pyrrolidin-3-one and/or 4-aminomethylene-pyrrolidin-3-alkoxyimino derivatives and/or gemifloxacin or a salt thereof
CA2458889C (en) * 2001-08-29 2011-06-21 Dow Global Technologies Inc. A process for preparing crystalline drug particles by means of precipitation
GB0125604D0 (en) * 2001-10-25 2001-12-19 Glaxo Group Ltd Novel process
GB0202564D0 (en) * 2002-02-04 2002-03-20 Glaxo Group Ltd Process
JP3691459B2 (ja) * 2002-06-14 2005-09-07 久光メディカル株式会社 粉末状吸入剤組成物
GB0216700D0 (en) * 2002-07-18 2002-08-28 Astrazeneca Ab Process
GB0300427D0 (en) * 2003-01-09 2003-02-05 Univ Strathclyde Pharmaceutical composition
US7638138B2 (en) 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
WO2004073827A1 (en) * 2003-02-21 2004-09-02 The University Of Bath Process for the production of particles
ATE435059T1 (de) * 2003-03-04 2009-07-15 Five Star Technologies Inc Verfahren zur kristallisation unter verwendung von hydrodynamischer kavitation
US7278982B2 (en) 2003-03-27 2007-10-09 Bioactis Limited Powder medicine applicator for nasal cavity
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
WO2005009375A2 (en) * 2003-07-22 2005-02-03 Baxter International Inc. Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
GB0404586D0 (en) * 2004-03-01 2004-04-07 Britannia Pharmaceuticals Ltd Improvements in or relating to organic materials
EP1785145A4 (de) 2004-08-10 2008-08-13 Translational Res Ltd Transnasale zusammensetzung mit sofortiger wirkung und hoher resorbierbarkeit
WO2006045795A2 (en) * 2004-10-29 2006-05-04 Akzo Nobel N.V. Processes involving the use of antisolvent crystallization
JPWO2006062129A1 (ja) * 2004-12-08 2008-06-12 株式会社クラレ （５α，７α）−３−スピロ−２’−（１’，３’−ジオキソラン）−２４−オキソコレスト−２２−エン−７−イルベンゾアートの製造方法
CN104177448A (zh) 2005-02-10 2014-12-03 葛兰素集团有限公司 使用预分选技术制备乳糖的方法以及由此形成的药物制剂
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
WO2008078730A1 (ja) 2006-12-26 2008-07-03 Translational Research, Ltd. 経鼻投与用製剤
GB0705159D0 (en) 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals
GB0707938D0 (en) 2007-04-25 2007-05-30 Univ Strathclyde Precipitation stabilising compositions
GB0724498D0 (en) 2007-12-15 2008-01-30 Univ Strathclyde Slow release compositions
ES2611031T3 (es) 2008-07-18 2017-05-04 Prosonix Limited Proceso de mejora de la cristalinidad
EP2429495A4 (de) 2009-05-15 2014-01-22 Shin Nippon Biomedical Lab Ltd Intranasale pharmazeutische zusammensetzung mit verbesserter pharmakokinetik
WO2011013003A2 (en) 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
PT105058B (pt) * 2010-04-21 2013-04-17 Hovione Farmaciencia S A Processo para processamento de partículas de ingredientes activos farmacêuticos
EP2729480A4 (de) * 2011-07-08 2014-12-31 Pfizer Ltd Verfahren zur herstellung von fluticasonpropionat der form 1
CN102366405A (zh) * 2011-10-21 2012-03-07 江阴长风医药科技有限公司 以氢氟烷烃为抛射剂的氟替卡松丙酸酯气雾剂制剂
WO2013105894A1 (en) * 2012-01-13 2013-07-18 Xspray Microparticles Ab A method for producing stable, amorphous hybrid nanoparticles comprising at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix- forming component.
KR102129426B1 (ko) 2012-05-08 2020-07-02 니콕스 오프탈믹스,아이엔씨. 소수성 치료제 제제, 그의 제조 방법 및 용도
US8765725B2 (en) 2012-05-08 2014-07-01 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
EP2705838A1 (de) * 2012-09-06 2014-03-12 Xspray Microparticles Ab Tiotropium-Zubereitungen
US9815865B2 (en) 2013-01-07 2017-11-14 Nicox Ophthalmics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
EP2991626A1 (de) * 2013-04-29 2016-03-09 Sanofi SA Inhalierbare pharmazeutische zusammensetzungen und inhaliervorrichtungen, die diese enthalten
PT108368B (pt) * 2015-03-31 2018-11-05 Hovione Farm S A Produção contínua de partículas
PT108885B (pt) * 2015-10-12 2019-02-13 Hovione Farm S A Método de produção de partículas compósitas inaláveis mediante a utilização de um atomizador de três fluidos
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
CN110960504A (zh) * 2019-10-31 2020-04-07 上海新黄河制药有限公司 中空颗粒制备方法及干粉吸入制剂
EP4210864A2 (de) * 2020-09-08 2023-07-19 Genentech, Inc. Systeme und verfahren zur herstellung pharmazeutischer zusammensetzungen mit peristaltischen pumpen und dämpfern
CN112755301B (zh) * 2021-01-20 2022-03-29 孙洪坤 一种血液病造血干细胞移植用皮肤清洁器

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404749D0 (en) 1984-02-23 1984-03-28 Atomic Energy Authority Uk Fluidic contactor
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
CA1282405C (en) * 1984-05-21 1991-04-02 Michael R. Violante Method for making uniformly sized particles from water-insoluble organic compounds
US4826589A (en) * 1988-06-30 1989-05-02 Gene Hirs Bar screen filter
GB8911259D0 (en) * 1989-05-17 1989-07-05 Fisons Plc Inhalation medicament
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
GB9007027D0 (en) 1990-03-29 1990-05-30 Atomic Energy Authority Uk Precipitation apparatus and method
GB9101967D0 (en) 1991-01-30 1991-03-13 Atomic Energy Authority Uk Reagent mixing
GB9320455D0 (en) 1993-10-05 1993-11-24 Atomic Energy Authority Uk Vortex mixer
GB9620187D0 (en) * 1996-09-27 1996-11-13 Minnesota Mining & Mfg Medicinal aerosol formulations

Also Published As

Publication number Publication date
HUP0203278A3 (en) 2004-06-28
EP1466595A1 (de) 2004-10-13
PT1225875E (pt) 2004-12-31
ES2225247T3 (es) 2005-03-16
NO20022059D0 (no) 2002-04-30
AU768915B2 (en) 2004-01-08
JP2003512892A (ja) 2003-04-08
WO2001032125A3 (en) 2002-05-16
ZA200203434B (en) 2003-02-25
HUP0203278A2 (hu) 2003-01-28
GB0024511D0 (en) 2000-11-22
NO20022059L (no) 2002-06-14
DE60012558D1 (de) 2004-09-02
HK1045268B (zh) 2005-02-18
NZ518565A (en) 2004-04-30
HK1045268A1 (en) 2002-11-22
PL356746A1 (en) 2004-06-28
BR0015271A (pt) 2002-12-31
CA2389908A1 (en) 2001-05-10
CN1409627A (zh) 2003-04-09
AU1160401A (en) 2001-05-14
DK1225875T3 (da) 2004-11-22
DE60012558T2 (de) 2005-07-28
GB9925934D0 (en) 1999-12-29
JP4700247B2 (ja) 2011-06-15
IL149366A0 (en) 2002-11-10
EP1225875B1 (de) 2004-07-28
MXPA02004394A (es) 2002-09-02
EP1225875A2 (de) 2002-07-31
WO2001032125A2 (en) 2001-05-10
CZ20021555A3 (cs) 2002-11-13
TR200402709T4 (tr) 2004-11-22
KR20020047322A (ko) 2002-06-21
SI1225875T1 (en) 2004-12-31

Similar Documents

Publication Publication Date Title
DE60012558D1 (de) Vorrichtung und verfahren zur herstellung von kristallinen partikeln
US4117048A (en) Apparatus for introducing gas into a liquid
JPH06508059A (ja) 排水を清澄にする方法および装置
DE60230449D1 (de) Vorrichtung und verfahren zum abtrennen und abfiltrieren von teilchen und organismen aus strömenden flüssigkeiten
FI116368B (fi) Kaasunkäsittely-/vaahdotusreaktori, jossa on laitteet kiintoaineiden erottamiseksi nesteistä
BG61437B1 (en) Cyclone with double-acting extraction system
JPH10503127A (ja) 流動性の媒体から液体を分離するための十字流−濾過方法およびこの方法を実施するためのプラント
RU2004120549A (ru) Способ и устройство для получения кристаллических частиц
US4193950A (en) Apparatus for introducing gas into a liquid
BR112012020630B1 (pt) sistema de recirculação de lama
ATE414563T1 (de) Verfahren und vorrichtung zur reinigung von luft mit gemischten flüssigkeiten
EP0829305A3 (de) Separator vom Flotationstyp
JPH07509181A (ja) 一定量の流れる液体に一定量の気体を溶解させる方法および装置
ATE82701T1 (de) Filtrationsverfahren und filtrationseinrichtung.
CN209193617U (zh) 一种流动混凝实验装置
JPH04290590A (ja) 浄化槽における膜分離装置
US5505840A (en) Chlorinator-filter system for sewage treatment plants
FR2801809B1 (fr) Procede de filtration membranaire de liquides et dispositif de mise en oeuvre dudit procede
FI95211C (fi) Menetelmä ja laitteisto flotaatiolaitokseen tai vastaavaan johdettavan puhdistettavan nestevirtauksen käsittelemiseksi
JPH02268890A (ja) 中空糸膜による汚水処理方法および装置
JP2000024420A (ja) 水の浄化システム
AU5414390A (en) Method and device for separation of materials suspended or dissolved in a liquid and application fields
CA3236948A1 (en) An apparatus for removing particulate materials from a liquid stream
KR100386168B1 (ko) 고도정수 처리시스템
SU1456159A1 (ru) Аппарат мембранной экстракции дл детоксикации биологических жидкостей

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1225875

Country of ref document: EP

REN Ceased due to non-payment of the annual fee